Recombinant Interferon Gamma in Treating Patients With Soft Tissue Sarcoma

NCT01957709 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

TERMINATED

Status

8

Enrollment

OTHER

Sponsor class

Stopped Enough samples were collected for data analysis.

Conditions

Myxoid Liposarcoma
Round Cell Liposarcoma
Synovial Sarcoma

Interventions

OTHER: Laboratory Biomarker Analysis
BIOLOGICAL: Recombinant Interferon Gamma

Sponsor

Fred Hutchinson Cancer Center

Collaborators

[object Object]
[object Object]